Header Logo

Connection

Grant Skrepnek to Piperazines

Back to Details
This is a "connection" page, showing publications Grant Skrepnek has written about Piperazines.
Grant Skrepnek
Connection Strength
0.234
Piperazines
  1. Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.